Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention
Steven R. Steinhubl, Kandice Kottke-Marchant, David J. Moliterno, Monique L. Rosenthal, Nikki K. Godfrey, Barry S. Coller, Eric J. Topol, A. Michael Lincoff
Research output: Contribution to journal › Article › peer-review
108Scopus
citations
Fingerprint
Dive into the research topics of 'Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention'. Together they form a unique fingerprint.